Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

Prostate cancer screening should be backed by ministers regardless of the advice from officials, Rishi Sunak has said.

Combining 177 Lu-PSMA-617 with SOC produced statistically significant rPFS, reducing the risk of radiographic progression or death by 28% (HR 0.72; 95% CI, 0.58-0.90) vs SOC alone in patients with ...

NHS data examined by Prostate Cancer UK revealed that 50,751 men were diagnosed with prostate cancer in 2022, exceeding the ...

Dr. Kelly Stratton answers the most frequently asked questions in prostate cancer regarding risk for recurrence, progression and treatment options. Navigating a prostate cancer diagnosis involves ...

A patient with prostate cancer receives radiotherapy. Hypofractionated radiotherapy (HRT) offers quality-of-life outcomes similar to conventional radiation therapy for men with low-risk prostate ...

Prostate cancer is the most common cancer that affects men globally, with an estimated 1.4 million new cases and 375,000 ...

A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell ...

Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce ...

September 10, 2007 —— Men with low-risk prostate cancer who opt for active surveillance should be encouraged to make dietary and lifestyle changes that improve their overall quality of life, such as ...

Among patients with grade group 1 prostate cancer, those belonging to higher risk groups were more likely to have adverse pathology and die from their disease. About 1 in 6 patients with grade group 1 ...